| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM061207R |
| P698 | PubMed publication ID | 17269759 |
| P50 | author | David Michael Andrews | Q38544031 |
| Helen P Price | Q56451052 | ||
| P2093 | author name string | Nigel R Parry | |
| George Burton | |||
| Claire Wilkinson | |||
| Pia Thommes | |||
| Richard L Jarvest | |||
| Martin J Slater | |||
| David Haigh | |||
| Pritom Shah | |||
| Rossella Guidetti | |||
| Gianpaolo Bravi | |||
| Richard Stocker | |||
| Peter D Howes | |||
| Stephanie Fernandes | |||
| Alan Wonacott | |||
| Onkar M P Singh | |||
| Deborah L Jackson | |||
| C David Hartley | |||
| John A Corfield | |||
| Anne G Cheasty | |||
| Elizabeth M Amphlett | |||
| Katrina J Medhurst | |||
| Malcolm R Ellis | |||
| Rebecca H Fenwick | |||
| Victoria L H Lovegrove | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | 897-900 | |
| P577 | publication date | 2007-02-02 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate | |
| P478 | volume | 50 |
| Q37945201 | Antiviral therapy for hepatitis C virus: beyond the standard of care |
| Q38365260 | Chiral gold(I) vs chiral silver complexes as catalysts for the enantioselective synthesis of the second generation GSK-hepatitis C virus inhibitor. |
| Q36836821 | Design and synthesis of L- and D-phenylalanine derived rhodanines with novel C5-arylidenes as inhibitors of HCV NS5B polymerase |
| Q56786308 | Emerging antiviral drugs |
| Q39487360 | Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors |
| Q33452082 | Insight into ligand selectivity in HCV NS5B polymerase: molecular dynamics simulations, free energy decomposition and docking |
| Q34387277 | MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles |
| Q34530512 | Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors |
| Q38087250 | New horizons in hepatitis C antiviral therapy with direct-acting antivirals. |
| Q37855859 | Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges |
| Q27656967 | Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymerase |
| Q43000504 | QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine |
| Q37481292 | Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection |
| Q37286829 | Stereoselective Synthesis of Quaternary Proline Analogues |
| Q43791105 | Stereoselective access to heteroarylmethylene-substituted pyrrolidines: fully organocatalytic Mannich-hydroamination reactions. |
| Q38034733 | Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research |
| Q92485714 | Synthesis of DNA-coupled isoquinolones and pyrrolidines by solid phase ytterbium- and silver-mediated imine chemistry |
Search more.